研究系统药物和生物制剂对中重度银屑病患者颈动脉内中膜厚度的影响
一项前瞻性研究纳入53例中重度银屑病患者,在启用系统药物或生物制剂前检测血脂、血糖及颈动脉内中膜厚度(IMT),并随访8个月。结果显示生物制剂组IMT呈下降趋势但未达统计学显著(P=0.086),甲氨蝶呤组(P=0.045)和抗IL-12/23组(P=0.010)IMT下降;TNF-α抑制剂和乌司奴单抗组血糖及胰岛素水平下降。作者认为颈动脉IMT可能从生物制剂治疗中获益,尤其抗IL-12/23和甲氨蝶呤。
要点
- 生物制剂组颈动脉IMT呈下降趋势,但未达统计学显著(P=0.086)。
- 甲氨蝶呤组(P=0.045)和抗IL-12/23组(P=0.010)IMT下降。
- TNF-α抑制剂和乌司奴单抗组血糖及胰岛素水平下降。
核心结论
- 本研究提示中重度银屑病患者的颈动脉IMT可能从生物制剂治疗中获益,尤其是抗IL-12/23和甲氨蝶呤。
- 作者指出需开展更大规模的纵向研究以充分证实这些结果。
研究设计与样本
- 前瞻性研究,纳入来自银屑病皮肤科单元的中重度银屑病患者53例。
- 在引入系统药物和生物制剂前分析脂质和糖代谢并行的颈动脉IMT超声检查,随后进行8个月的密切分析和超声随访。
主要发现
- 接受生物制剂治疗的银屑病患者IMT呈下降趋势,但未达统计学显著(P=0.086)。
- 亚组分析显示接受甲氨蝶呤治疗的患者IMT水平下降(P=0.045)。
- 亚组分析显示接受抗IL-12/23治疗的患者IMT水平下降(P=0.010)。
- 亚组分析显示接受TNF-α抑制剂和乌司奴单抗治疗的患者血糖和胰岛素水平下降。
临床怎么用
- 作者认为颈动脉IMT可能从生物制剂治疗中获益,尤其是抗IL-12/23和甲氨蝶呤。
- 作者指出需开展更大规模的纵向研究以充分证实这些结果。
局限性
- 作者指出需开展更大规模的纵向研究以充分证实这些结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Psoriasis has been related to a large number of cardiovascular risk factors such as hypertension, diabetes mellitus and arteriosclerosis. The increased carotid intima-media thickness (IMT) could be considered to be a marker of generalized arteriosclerosis. OBJECTIVE: To assess the effect of systemic and biological drugs on psoriatic patients' carotid IMT. METHODS: A prospective study was performed. We studied 53 patients with moderate and severe psoriasis from our psoriasis dermatological unit, analysing lipid and glucose metabolism and performing a carotid IMT sonography before introduction of systemic and biological drugs. After that, we performed an 8-month closely analytic and sonographic follow-up. RESULTS: The IMT of the patients with psoriasis treated with biological drugs tended to decrease, although this occurrence was not statistically significant (P = 0.086). The subgroup analysis revealed that patients treated with methotrexate (P = 0.045) and anti-IL-12/23 (P = 0.010) presented a decrease in their IMT levels. This analysis also showed a decrease in glycaemia and insulin levels in patients treated with TNF-alpha inhibitors and ustekinumab. CONCLUSIONS: Our study suggests that the carotid IMT may benefit from treatment with biological drugs, particularly anti-IL-12/23 and methotrexate in patients suffering from moderate and severe psoriasis. However, larger longitudinal studies should be performed to fully confirm these results.
引用
- Martinez-Lopez A, Blasco-Morente G, Perez-Lopez I, et al. Studying the effect of systemic and biological drugs on intima-media thickness in patients suffering from moderate and severe psoriasis. J Eur Acad Dermatol Venereol. 2018. PMID: 29405437. doi:10.1111/jdv.14841
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。